Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes

NCT01276288 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 10773
DRUG: hydrochlorothiazide
DRUG: torasemide
DRUG: BI 10773
DRUG: torasemide
DRUG: BI 10773
DRUG: hydrochlorothiazide

Sponsor

Boehringer Ingelheim